General Internal Medicine

Pulmonary Embolus

Questions discussed in this category

Are you more permissive of perioperative interruption of anticoagulation for VTE depending on the location and relative chronicity of the thrombus?

1 Answer available

For patients with newly diagnosed VTE on IV heparin planned for transition to DOAC, would you start at the loading or maintenance DOAC dose?

If they have been on IV heparin for 3 days, for example, would you subtract those days from the recommended loading dose time?

5 Answers available

How do you counsel an otherwise healthy patient on how soon they can go back to moderate exercise after a bilateral pulmonary embolism?

1 Answer available

How does your approach to subsegmental PE differ from segmental PE both diagnostically and therapeutically?

3 Answers available

How would you manage a patient with morbid obesity who presents with new symptomatic pulmonary embolism a few days after he was started on DOAC for DVT?

What is your preferred anticoagulation in patients with BMI >50?

5 Answers available

Papers discussed in this category

J Thromb Haemost, 2021 Jul 14

Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation.

Blood, 2020 Mar 19

How I treat obese patients with oral anticoagulants.

JAMA network open, 2023 Aug 01

Prevalence of and Eligibility for Surveillance Without Anticoagulation Among Adults With Lower-Risk Acute Subsegmental Pulmonary Embolism.

Blood, 2013 Jun 04

Risk profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism.

Annals of internal medicine, 2021 Nov 23

Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study.

AJR Am J Roentgenol,

Overdiagnosis of Pulmonary Embolism by Pulmonary CT Angiography.

Journal of thrombosis and haemostasis : JTH, 2008-08

Comparison between idiopathic deep vein thrombosis of the upper and lower extremity regarding risk factors and recurrence.

BMJ (Clinical research ed.), 2011 May 24

Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials.

Related Topics in General Internal Medicine